Abstract:The IT increases linearly with increasing crown-rump length and seems to be of value in the first-trimester detection of spina bifida. It is easy to identify and measure and shows excellent intra-observer and inter-observer reproducibility measurements.
“…In our prospective study, after specific training for intracranial translucency visualization, 10 nonphysician sonographers were able to obtain adequate images of the posterior brain structures, with intracranial translucency visualization in 96% of normal fetuses at the time of the 11‐ to 13‐week nuchal translucency ultrasound scan. This rate is comparable to the intracranial translucency visualization rates of 97% to 100% reported by 2 recent prospective studies in which the 11‐ to 13‐week scans were performed by highly skilled obstetricians with considerable experience in first‐trimester scanning 6 , 14 . Our study suggests that it is feasible to introduce the intracranial translucency technique in conjunction with nuchal translucency screening by adequately trained nonphysician sonographers at 11 to 13 weeks' gestation.…”
Section: Discussionsupporting
confidence: 82%
“…Several studies have reported on measurement of the anteroposterior diameter of intracranial translucency and reference ranges in normal fetuses, demonstrating that intracranial translucency increases linearly with increasing crown‐rump length 1 , 6 , 16 . Manual measurements of intracranial translucency have been shown to be reproducible 6 , 16 .…”
Section: Discussionmentioning
confidence: 99%
“…Several studies have reported on measurement of the anteroposterior diameter of intracranial translucency and reference ranges in normal fetuses, demonstrating that intracranial translucency increases linearly with increasing crown‐rump length 1 , 6 , 16 . Manual measurements of intracranial translucency have been shown to be reproducible 6 , 16 . A retrospective study of stored images showed that intracranial translucency can also be measured reliably using a semi‐automated caliper placement technique introduced for nuchal translucency measurement (SonoNT; GE Medical Systems, Zipf, Austria) 17 .…”
Intracranial translucency can be prospectively identified by trained sonographers in 96% of normal fetuses at 11 to 13 weeks. Measurements of brain stem and brain stem-occipital bone diameters are reproducible.
“…In our prospective study, after specific training for intracranial translucency visualization, 10 nonphysician sonographers were able to obtain adequate images of the posterior brain structures, with intracranial translucency visualization in 96% of normal fetuses at the time of the 11‐ to 13‐week nuchal translucency ultrasound scan. This rate is comparable to the intracranial translucency visualization rates of 97% to 100% reported by 2 recent prospective studies in which the 11‐ to 13‐week scans were performed by highly skilled obstetricians with considerable experience in first‐trimester scanning 6 , 14 . Our study suggests that it is feasible to introduce the intracranial translucency technique in conjunction with nuchal translucency screening by adequately trained nonphysician sonographers at 11 to 13 weeks' gestation.…”
Section: Discussionsupporting
confidence: 82%
“…Several studies have reported on measurement of the anteroposterior diameter of intracranial translucency and reference ranges in normal fetuses, demonstrating that intracranial translucency increases linearly with increasing crown‐rump length 1 , 6 , 16 . Manual measurements of intracranial translucency have been shown to be reproducible 6 , 16 .…”
Section: Discussionmentioning
confidence: 99%
“…Several studies have reported on measurement of the anteroposterior diameter of intracranial translucency and reference ranges in normal fetuses, demonstrating that intracranial translucency increases linearly with increasing crown‐rump length 1 , 6 , 16 . Manual measurements of intracranial translucency have been shown to be reproducible 6 , 16 . A retrospective study of stored images showed that intracranial translucency can also be measured reliably using a semi‐automated caliper placement technique introduced for nuchal translucency measurement (SonoNT; GE Medical Systems, Zipf, Austria) 17 .…”
Intracranial translucency can be prospectively identified by trained sonographers in 96% of normal fetuses at 11 to 13 weeks. Measurements of brain stem and brain stem-occipital bone diameters are reproducible.
“…Since then, five prospective studies looking at different posterior fossa components, including the IT as one of the components, have been reported . The largest is a multicentre prospective study by Chen et al .…”
We consider that acquisition of an image of the IT as part of the routine first trimester nuchal translucency scan is feasible, without lengthening appointment times.
“…In a study including 990 fetuses Adiego et al reported that the mean IT anteroposterior diameter was 1.8 mm (range 0.8-3.1) [14] . In another study including 201 singleton fetuses median IT value for the first trimester was 1.7 mm (range 1-2.4) [15] .…”
Spina bifida is the one of the most common severe congenital abnormality of the central nervous system. Scalloping of the frontal bones called "the lemon sign" and caudal displacement of the cerebellum called "the banana sign" are known as cranial signs of open spina bifida on ultrasonography at the second trimester. Although these signs are useful methods in diagnosing of open spina bifida in the second trimester, detection rates of open spina bifida by using these signs in the first trimester are low. Intracranial translucency is a new sonographic landmark that may be valuable for the early detection of open spina bifida in the first trimester.In this study using of intracranial translucency as a sonographic marker of open spina bifida at first trimester is discussed with the light of recent literature.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.